HomeABC • VIE
Cencora Inc
€237.50
Feb 11, 5:50:05 PM GMT+1 · EUR · VIE · Disclaimer
StockAT listed security
Previous close
€240.45
Day range
€237.50 - €238.90
Year range
€197.88 - €250.25
Market cap
10.91B USD
Avg Volume
5.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
81.49B12.78%
Operating expense
1.75B4.96%
Net income
488.60M-18.77%
Net profit margin
0.60-27.71%
Earnings per share
3.7313.72%
EBITDA
1.07B2.27%
Effective tax rate
20.43%
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
3.22B12.25%
Total assets
69.05B6.75%
Total liabilities
68.69B7.96%
Total equity
361.90M
Shares outstanding
193.76M
Price to book
128.58
Return on assets
2.91%
Return on capital
26.53%
Net change in cash
(USD)Dec 2024Y/Y change
Net income
488.60M-18.77%
Cash from operations
-2.72B-407.15%
Cash from investing
-343.04M-421.34%
Cash from financing
3.21B681.72%
Net change in cash
97.09M-65.72%
Free cash flow
-2.73B-410.93%
About
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It is considered one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products as well as home healthcare supplies and equipment. Wikipedia
Founded
1871
Employees
46,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu